3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
41
Squamous Cell Carcinoma of Head and Neck
20
Lung Neoplasms
20
Urinary Bladder Neoplasms
9
Oropharyngeal Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Carcinoma
7
Uterine Cervical Neoplasms
6
Endometrial Neoplasms
6
Biliary Tract Neoplasms
6
Pancreatic Neoplasms
5
Mouth Neoplasms
5
Colorectal Neoplasms
5
Cholangiocarcinoma
5
Neoplasms
4
Neoplasm Metastasis
4
Nasopharyngeal Carcinoma
4
Laryngeal Neoplasms
4
Head and Neck Neoplasms
4
Carcinoma, Squamous Cell
4
Mesothelioma, Malignant
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Triple Negative Breast Neoplasms
2
Tongue Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Salivary Gland Neoplasms
2
Rectal Neoplasms
2
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Cisplatin
×
30 days
×
Clear all
No trials found.